Biotech »

Resverlogix’s BETonMACE trial gets fourth positive rec

Resverlogix’s BETonMACE trial gets fourth positive rec

Alpha Stox June 28, 2017 0

Dr. Michael Sweeney reports RESVERLOGIX ANNOUNCES FOURTH POSITIVE RECOMMENDATION FROM DATA SAFETY MONITORING BOARD FOR PHASE 3 STUDY OF APABETALONE The independent data and safety monitoring board (DSMB) for Resverlogix Corp.’s phase 3 BETonMACE

Read More »
Kalytera’s Salzman quits as CEO, CMO, director

Kalytera’s Salzman quits as CEO, CMO, director

Alpha Stox June 22, 2017 0

Mr. Robert Farrell reports KALYTERA ANNOUNCES MANAGEMENT CHANGES AND EXPANSION OF LEADERSHIP TEAM Dr. Andrew L. Salzman, MD, who previously served as Kalytera Therapeutics Inc.’s chief executive officer and chief medical officer, and as

Read More »
BELLUS Health announces sale of its equity interest in FB Health for total consideration up to CA$2.5M

BELLUS Health announces sale of its equity interest in FB Health for total consideration up to CA$2.5M

Alpha Stox June 19, 2017 0

LAVAL, QC, June 19, 2017 /CNW/ - BELLUS Health Inc. (TSX: BLU) (BELLUS Health or the Company), a biopharmaceutical development company advancing novel therapeutics for conditions with high unmet medical need, today announced the sale of its equity interest

Read More »
RepliCel Life, UBC to perform hair follicle study

RepliCel Life, UBC to perform hair follicle study

Alpha Stox June 13, 2017 Comments Off

Mr. Lee Buckler reports REPLICEL COLLABORATES WITH UNIVERSITY OF BRITISH COLUMBIA TO BUILD WORLD-CLASS HAIR FOLLICLE CELL DATA MAP RepliCel Life Sciences Inc. has signed a collaborative research project agreement with the University of

Read More »
Kane Biotech arranges $4-million placement

Kane Biotech arranges $4-million placement

Alpha Stox June 1, 2017 Comments Off

Mr. Mark Ahrens-Townsend reports KANE BIOTECH ANNOUNCES PRIVATE PLACEMENT OFFERING Kane Biotech Inc. intends to undertake a non-brokered private placement offering of up to 33,333,333 units at a price of 12 cents per unit

Read More »
Revive, UW Madison enter cannabinoid research agreement

Revive, UW Madison enter cannabinoid research agreement

Alpha Stox May 30, 2017 Comments Off

Mr. Craig Leon reports REVIVE THERAPEUTICS ANNOUNCES SPONSORED RESEARCH AGREEMENT WITH THE UNIVERSITY OF WISCONSIN-MADISON TO EVALUATE A NOVEL DRUG DELIVERY TECHNOLOGY FOCUSED ON CANNABINOIDS Revive Therapeutics Ltd. has entered into a sponsored research

Read More »
Veritas Pharma increases lab staff for clinical trial

Veritas Pharma increases lab staff for clinical trial

Alpha Stox May 8, 2017 Comments Off

Dr. Lui Franciosi reports CANNEVERT PRESSES ON TO ITS GOAL OF CLINICAL TRIALS Veritas Pharma Inc.’s research arm, Cannevert Therapeutics Ltd. is moving swiftly toward properly certified and scientifically rigorous clinical trials of a

Read More »
SQI Diagnostics to provide Q2 results May 10

SQI Diagnostics to provide Q2 results May 10

Alpha Stox May 3, 2017 Comments Off

Toronto, Ontario, May 3, 2017 SQI Diagnostics Inc. (“SQI Diagnostics” or the “Company”) (TSX-V: SQD; OTCQX: SQIDF), today announced that it plans to release its financial and operational results for the three and six

Read More »
SQI Diagnostics to exhibit at biotechnology conference

SQI Diagnostics to exhibit at biotechnology conference

Alpha Stox May 1, 2017 Comments Off

Mr. Andrew Morris reports SQI DIAGNOSTICS TO EXHIBIT AT THE NATIONAL BIOTECHNOLOGY CONFERENCE SQI Diagnostics Inc. will be exhibiting at the American Association of Pharmaceutical Scientists (AAPS) National Biotechnology Conference in San Diego, Calif.

Read More »
RepliCel Life receives U.S. patent for injection device

RepliCel Life receives U.S. patent for injection device

Alpha Stox April 25, 2017 Comments Off

Mr. Lee Buckler reports UNITED STATES PATENT ISSUED TO REPLICEL FOR ITS NOVEL DERMAL INJECTION TECHNOLOGIES RepliCel Life Sciences Inc. has been granted a key patent in the United States (U.S. patent No. 9,616,182)

Read More »
Newsletterpopup_top_1

Your Name (required)

Your Email (required)

captcha

Newsletterpopup_bottom_1